When PD-1 knock-out mice were challenged with C1498 cells, they exhibited enhanced antitumor T-cell responses, reduced AML burden in the blood and tissues, and had significantly prolonged survival compared to wild-type mice. This evidence concerns the gene PDCD1 and acute myeloid leukemia.